JP5721950B2 - 選択された遺伝子のエピジェネティックな変化及び癌 - Google Patents

選択された遺伝子のエピジェネティックな変化及び癌 Download PDF

Info

Publication number
JP5721950B2
JP5721950B2 JP2009545222A JP2009545222A JP5721950B2 JP 5721950 B2 JP5721950 B2 JP 5721950B2 JP 2009545222 A JP2009545222 A JP 2009545222A JP 2009545222 A JP2009545222 A JP 2009545222A JP 5721950 B2 JP5721950 B2 JP 5721950B2
Authority
JP
Japan
Prior art keywords
gene
cancer
dna
ndrg4
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009545222A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010515448A (ja
JP2010515448A5 (https=
Inventor
インゲランド， マノン ヴァン
インゲランド， マノン ヴァン
ブルイン， マノン， エイドリアーン デ
ブルイン， マノン， エイドリアーン デ
アルヤン グリフィオネン，
アルヤン グリフィオネン，
ユースト ルーヴァギー，
ユースト ルーヴァギー，
カーチャ ビロー，
カーチャ ビロー，
ゴントラン ブリチャード，
ゴントラン ブリチャード，
ゴエタン オット，
ゴエタン オット，
マーテン ペニング，
マーテン ペニング，
Original Assignee
エムディーエックスヘルス エスエー
エムディーエックスヘルス エスエー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37801915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5721950(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by エムディーエックスヘルス エスエー, エムディーエックスヘルス エスエー filed Critical エムディーエックスヘルス エスエー
Publication of JP2010515448A publication Critical patent/JP2010515448A/ja
Publication of JP2010515448A5 publication Critical patent/JP2010515448A5/ja
Application granted granted Critical
Publication of JP5721950B2 publication Critical patent/JP5721950B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2009545222A 2007-01-09 2008-01-09 選択された遺伝子のエピジェネティックな変化及び癌 Active JP5721950B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US87933207P 2007-01-09 2007-01-09
GBGB0700374.2A GB0700374D0 (en) 2007-01-09 2007-01-09 NDRG family methylation markers
US60/879,332 2007-01-09
GB0700374.2 2007-01-09
US96013007P 2007-09-17 2007-09-17
US60/960,130 2007-09-17
US97826107P 2007-10-08 2007-10-08
US60/978,261 2007-10-08
PCT/GB2008/000056 WO2008084219A1 (en) 2007-01-09 2008-01-09 Epigenetic change in selected genes and cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015062366A Division JP6141896B2 (ja) 2007-01-09 2015-03-25 選択された遺伝子のエピジェネティックな変化及び癌

Publications (3)

Publication Number Publication Date
JP2010515448A JP2010515448A (ja) 2010-05-13
JP2010515448A5 JP2010515448A5 (https=) 2011-03-03
JP5721950B2 true JP5721950B2 (ja) 2015-05-20

Family

ID=37801915

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009545222A Active JP5721950B2 (ja) 2007-01-09 2008-01-09 選択された遺伝子のエピジェネティックな変化及び癌
JP2015062366A Active JP6141896B2 (ja) 2007-01-09 2015-03-25 選択された遺伝子のエピジェネティックな変化及び癌

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015062366A Active JP6141896B2 (ja) 2007-01-09 2015-03-25 選択された遺伝子のエピジェネティックな変化及び癌

Country Status (7)

Country Link
US (6) US8969046B2 (https=)
EP (3) EP2069527B1 (https=)
JP (2) JP5721950B2 (https=)
CN (1) CN101680025A (https=)
CA (1) CA2674988C (https=)
GB (1) GB0700374D0 (https=)
WO (1) WO2008084219A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015154775A (ja) * 2007-01-09 2015-08-27 エムディーエックスヘルス エスエー 選択された遺伝子のエピジェネティックな変化及び癌

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005017207A2 (en) * 2003-08-14 2005-02-24 Case Western Reserve University Methods and compositions for detecting colon cancers
US8415100B2 (en) 2003-08-14 2013-04-09 Case Western Reserve University Methods and compositions for detecting gastrointestinal and other cancers
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
CA2676227A1 (en) * 2007-02-12 2008-08-21 The Johns Hopkins University Early detection and prognosis of colon cancers
CA2699853A1 (en) 2007-09-17 2009-03-26 Oncomethylome Sciences Sa Improved detection of mage-a expression
EP2816122A1 (en) 2008-02-15 2014-12-24 Mayo Foundation For Medical Education And Research Detecting neoplasm from a stool sample
US20110117551A1 (en) * 2008-02-19 2011-05-19 Oncomethylome Sciences Sa Detection and prognosis of lung cancer
WO2009115615A2 (en) * 2008-03-21 2009-09-24 Oncomethylome Sciences S.A. Detection and prognosis of cervical cancer
BRPI0913578A2 (pt) 2008-05-14 2017-06-06 Dermtech Int diagnose de melanoma e lentigo solar por análise de ácido nucléico
US9249465B2 (en) * 2008-09-22 2016-02-02 Advpharma, Inc. Molecular markers for lung and colorectal carcinomas
DK2394170T3 (en) * 2009-02-03 2015-07-13 Mdxhealth Sa Methods for detecting colorectal cancer
CA2755358A1 (en) 2009-03-13 2010-09-16 Mdxhealth Sa Novel markers for bladder cancer detection
CA2779223A1 (en) 2009-10-27 2011-05-12 Caris Mpi, Inc. Molecular profiling for personalized medicine
EP2354242A1 (en) * 2010-02-03 2011-08-10 Epiontis GmbH Assay for determining the type and/or status of a cell based on the epigenetic pattern and the chromatin structure
US20110236916A1 (en) 2010-03-26 2011-09-29 Mayo Foundation For Medical Education And Research Methods and materials for detecting colorectal neoplasm
WO2011135058A2 (en) 2010-04-30 2011-11-03 Mdxhealth Sa Methods for detecting epigenetic modifications
EP2569452B1 (en) * 2010-05-14 2020-03-25 Life Technologies Corporation Karyotyping assay
JP6222202B2 (ja) * 2010-07-05 2017-11-01 ソニー株式会社 生体情報処理方法および装置、並びに記録媒体
JP5838557B2 (ja) * 2010-07-05 2016-01-06 ソニー株式会社 生体情報処理方法および装置、並びに記録媒体
US8916344B2 (en) 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
EP3441479B1 (en) * 2011-02-02 2020-09-02 Exact Sciences Development Company, LLC Digital sequence analysis of dna methylation
US8993341B2 (en) 2011-05-12 2015-03-31 Exact Sciences Corporation Removal of PCR inhibitors
CN103649298A (zh) 2011-05-12 2014-03-19 精密科学公司 核酸的分离
JP2014533100A (ja) * 2011-11-04 2014-12-11 オスロ ウニヴェルスィテーツスィーケフース ハーエフＯｓｌｏ Ｕｎｉｖｅｒｓｉｔｅｔｓｓｙｋｅｈｕｓ Ｈｆ 結腸直腸癌の分析のための方法およびバイオマーカー
CA2858144C (en) 2011-12-06 2021-05-04 Mdxhealth Sa Methods of detecting mutations and epigenetic changes
US9744155B2 (en) 2012-03-28 2017-08-29 Ixcela, Inc. IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
MX2014014356A (es) 2012-05-24 2015-07-06 Fundació Inst D Investigació Biomédica De Bellvitge Idibell Metodo para la identificacion del origen de un cancer de origen primario desconocido.
AU2012388616A1 (en) * 2012-08-31 2015-04-02 National Defense Medical Center Method for screening cancer
CN102787174B (zh) * 2012-09-06 2013-08-07 南京大学 胃肠肿瘤发病相关抑癌基因表观突变检测试剂盒及其用途
EP2929350A4 (en) * 2012-12-04 2016-11-16 Caris Mpi Inc MOLECULAR PROFILING OF CANCER
ES2859645T3 (es) 2013-03-14 2021-10-04 Mayo Found Medical Education & Res Detección de neoplasia
US9644232B2 (en) * 2013-07-26 2017-05-09 General Electric Company Method and device for collection and amplification of circulating nucleic acids
WO2015066695A1 (en) * 2013-11-04 2015-05-07 Exact Sciences Corporation Multiple-control calibrators for dna quantitation
EP2886659A1 (en) * 2013-12-20 2015-06-24 AIT Austrian Institute of Technology GmbH Gene methylation based colorectal cancer diagnosis
CN105934520A (zh) * 2014-01-31 2016-09-07 伊克斯塞拉有限公司 作为生物标志物的共价键代谢物
WO2019161126A1 (en) 2018-02-14 2019-08-22 Dermtech, Inc. Novel gene classifiers and uses thereof in non-melanoma skin cancers
JP2015177745A (ja) * 2014-03-18 2015-10-08 愛知県 肺癌の検査方法
EP4234722A3 (en) 2014-03-31 2023-09-20 Mayo Foundation for Medical Education and Research Detecting colorectal neoplasm
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
CN104561258B (zh) * 2014-10-08 2016-08-24 王红卫 一种用于直结肠癌早期诊断的检测试剂盒及其应用
GB201418965D0 (https=) 2014-10-24 2014-12-10 Ospedale San Raffaele And Fond Telethon
US20170322218A1 (en) 2014-11-27 2017-11-09 Public University Corporation Yokohama City University Method and reagent for detecting ovarian clear cell adenocarcinoma
US9984201B2 (en) 2015-01-18 2018-05-29 Youhealth Biotech, Limited Method and system for determining cancer status
US10030272B2 (en) 2015-02-27 2018-07-24 Mayo Foundation For Medical Education And Research Detecting gastrointestinal neoplasms
CN107532124B (zh) 2015-03-27 2022-08-09 精密科学公司 检测食管疾病
JP2016192909A (ja) * 2015-03-31 2016-11-17 シスメックス株式会社 胃癌に関する情報の取得方法、ならびに胃癌に関する情報を取得するためのマーカーおよび胃癌検出用キット
CN108138235B (zh) 2015-08-31 2022-04-15 梅约医药教育及研究基金会 检测胃肿瘤
CN108473932B (zh) 2015-09-09 2022-07-15 集联健康有限公司 用于样品收集、稳定化和保存的系统、方法和装置
CN105177163B (zh) * 2015-10-21 2018-04-13 山东大学齐鲁医院 一种用于宫颈癌早期筛查的试剂盒
AU2016343937B2 (en) 2015-10-30 2023-01-19 Exact Sciences Corporation Multiplex amplification detection assay and isolation and detection of DNA from plasma
CA3020628A1 (en) 2016-04-14 2017-10-19 Mayo Foundation For Medical Education And Research Detecting pancreatic high-grade dysplasia
US10370726B2 (en) 2016-04-14 2019-08-06 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasia
US10202650B2 (en) 2016-05-31 2019-02-12 Youhealth Biotech, Limited Methods for monitoring ELOVL2, KLF14 and PENK gene expression following treatment with vitamin C
CN106119361B (zh) * 2016-06-28 2020-01-07 宁波思锐生物科技有限公司 用于胃癌早期诊断及预后评估的ndrg4基因甲基化检测的试剂盒及其应用
CN106011263B (zh) * 2016-06-28 2020-01-07 宁波大学 用于检测与胃癌相关的ndrg4基因甲基化程度的试剂盒及其应用
WO2018009696A1 (en) 2016-07-06 2018-01-11 Youhealth Biotech, Limited Colon cancer methylation markers and uses thereof
US10093986B2 (en) 2016-07-06 2018-10-09 Youhealth Biotech, Limited Leukemia methylation markers and uses thereof
EP3481403B1 (en) 2016-07-06 2022-02-09 Youhealth Biotech, Limited Solid tumor methylation markers and uses thereof
EP3481941A4 (en) 2016-07-06 2020-04-15 Youhealth Biotech, Limited METHYLIZATION MARKERS FOR BREAST AND OVARIAL CANCER AND THEIR USE
WO2018009705A1 (en) 2016-07-06 2018-01-11 Youhealth Biotech, Limited Liver cancer methylation markers and uses thereof
CN109415771A (zh) * 2016-07-08 2019-03-01 哈鲁曼有限公司 大肠癌发病可能性的判定方法
CN106521006A (zh) * 2016-12-27 2017-03-22 刘鹏飞 Ndrg4基因甲基化检测用试剂体系和试剂盒及其应用
TWI882519B (zh) 2017-01-10 2025-05-01 美商集聯健康有限公司 用於收集和儲存來自受試者之血液的裝置
CN108300783A (zh) * 2017-01-11 2018-07-20 上海易毕恩基因科技有限公司 用于筛选肠癌和/或胃癌的基因标志物的方法、用该方法筛选的基因标志物及其用途
KR102892245B1 (ko) 2017-01-27 2025-11-27 이그젝트 싸이언스 디블롭먼트 컴패니, 엘엘씨 메틸화된 dna 분석에 의한 결장 신조직형성의 검출
CN110431241B (zh) 2017-02-28 2024-04-19 梅约医学教育与研究基金会 检测前列腺癌
BR112019018272A2 (pt) 2017-03-02 2020-07-28 Youhealth Oncotech, Limited marcadores metilação para diagnosticar hepatocelular carcinoma e câncer
CA3065423A1 (en) * 2017-06-02 2018-12-06 Peter Dominiek Emiel Maria VERHAERT Mass spectrometry histochemistry of peptides from formaldehyde-fixed, paraffin-embedded tissue
CN107177679A (zh) * 2017-06-07 2017-09-19 北京呈诺医学科技有限公司 一种检测食管鳞癌相关基因tfpi2和hspb2启动子甲基化程度的试剂盒
US11433074B2 (en) 2017-06-22 2022-09-06 Triact Therapeutics, Inc. Methods of treating glioblastoma
IT201700072650A1 (it) * 2017-06-28 2018-12-28 Univ Degli Studi Cagliari Metodo per rilevare e/o per la prognosi di neoplasie del colon-retto
US11628144B2 (en) 2017-09-29 2023-04-18 Triact Therapeutics, Inc. Iniparib formulations and uses thereof
BR112020006912A2 (pt) 2017-10-06 2020-12-22 Youhealth Oncotech, Limited Marcadores de metilação para diagnóstico de câncer
KR102052089B1 (ko) * 2017-11-22 2019-12-05 연세대학교 산학협력단 유전자의 CpG 메틸화 변화를 이용한 간암의 위험도를 평가하는 방법
US10975443B2 (en) 2017-11-30 2021-04-13 Mayo Foundation For Medical Education And Research Detecting breast cancer
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
CN111989407B (zh) 2018-03-13 2024-10-29 格里尔公司 异常的片段检测及分类
CN108460247B (zh) * 2018-03-29 2022-06-07 上海锐翌生物科技有限公司 基于kras和ndrg4基因确定结直肠肿瘤细胞的方法和系统
CN119753091A (zh) 2018-04-02 2025-04-04 格里尔公司 用于扩增与癌症相关联的cfDNA分子的化验板
CN108707667B (zh) * 2018-06-01 2021-10-26 安徽达健医学科技有限公司 一种用于结直肠癌早期诊断的试剂盒及其使用方法
CA3136405A1 (en) * 2018-06-01 2019-12-05 Geneoscopy, Inc. Detection method for cancer using rna biomarkers
CN108796078B (zh) * 2018-06-05 2022-07-26 苏州唯善生物科技有限公司 一种用于消化道癌诊断、检测或筛查的引物和探针组
CN108977543B (zh) * 2018-08-06 2021-12-14 上海锐翌生物科技有限公司 一种基于联合检测sdc2和sfrp2基因甲基化水平的结直肠癌早期诊断试剂
US11441182B2 (en) * 2018-08-08 2022-09-13 Virginia Commonwealth University Multiplexed and recyclable single-molecule sensors for quantitative analysis of nucleic-acid biomarkers
IL281741B2 (en) 2018-09-27 2026-04-01 Grail Inc Methylation markers and a targeted methylation detection panel
US12404540B2 (en) 2018-10-17 2025-09-02 The University Of Queensland Epigenetic biomarker and uses therefor
JP7462632B2 (ja) 2018-11-30 2024-04-05 カリス エムピーアイ インコーポレイテッド 次世代分子プロファイリング
WO2020132572A1 (en) 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
US12584177B2 (en) 2019-01-24 2026-03-24 Mayo Foundation For Medical Education And Research Detecting endometrial cancer
US11041847B1 (en) 2019-01-25 2021-06-22 Ixcela, Inc. Detection and modification of gut microbial population
WO2020198229A1 (en) 2019-03-26 2020-10-01 Dermtech, Inc. Novel gene classifiers and uses thereof in skin cancers
CN109943638A (zh) * 2019-05-08 2019-06-28 湖南百伯基因技术有限公司 一种检测ndrg4、sdc2和bmp3基因甲基化的引物探针组合及其应用和试剂盒
US11396679B2 (en) 2019-05-31 2022-07-26 Universal Diagnostics, S.L. Detection of colorectal cancer
CN110283911A (zh) * 2019-06-28 2019-09-27 四川沃文特生物技术有限公司 用于粪便样本进行早期结直肠癌基因甲基化检测的引物对和探针及试剂盒
CN110343764B (zh) * 2019-07-22 2020-05-26 武汉艾米森生命科技有限公司 检测结直肠癌相关基因甲基化的检测试剂的应用和试剂盒
US11427874B1 (en) 2019-08-26 2022-08-30 Epi One Inc. Methods and systems for detection of prostate cancer by DNA methylation analysis
CA3154354A1 (en) 2019-10-31 2021-05-06 William R. Taylor Detecting ovarian cancer
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
WO2021112918A1 (en) 2019-12-02 2021-06-10 Caris Mpi, Inc. Pan-cancer platinum response predictor
EP4100955A4 (en) * 2020-02-06 2024-02-28 Oncohost Ltd MACHINE LEARNING PREDICTION OF THERAPEUTIC RESPONSE
CN111549129B (zh) * 2020-03-30 2023-08-29 宁波美康盛德医学检验所有限公司 用于检测胃癌的试剂盒及其应用
JP7843243B2 (ja) * 2020-04-30 2026-04-09 ガーダント ヘルス， インコーポレイテッド 分配された核酸を使用した配列決定のための方法
WO2021228418A1 (en) 2020-05-15 2021-11-18 Universal Diagnostics, S.L. Methods and systems for identifying methylation biomarkers
WO2022002424A1 (en) 2020-06-30 2022-01-06 Universal Diagnostics, S.L. Systems and methods for detection of multiple cancer types
CN113699237A (zh) * 2020-07-29 2021-11-26 上海吉凯医学检验所有限公司 一种检测早期结直肠癌和腺瘤的dna甲基化标志物的试剂盒
CN112941162A (zh) * 2020-12-30 2021-06-11 昆明理工大学 一种dna端粒长度和基因甲基化程度相关性的检测方法
WO2022192510A1 (en) * 2021-03-10 2022-09-15 University Of Cincinnati Epigenetic quantification using dna hybridization-based single-molecule immunofluorescent imaging
CN113234821B (zh) * 2021-04-29 2022-09-16 北京艾克伦医疗科技有限公司 鉴定食管癌状态的方法和试剂盒
EP4320276B1 (en) * 2021-05-14 2025-04-23 Universal Diagnostics S.A. Methods for disease detection
WO2022238559A1 (en) * 2021-05-14 2022-11-17 Universal Diagnostics Sl Methods for disease detection
EP4409036A1 (en) 2021-09-30 2024-08-07 Tivenix SA A method for diagnosing and predicting progression of neurodegenerative diseases or disorders
JP2025520370A (ja) * 2022-06-17 2025-07-03 コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジー びまん型胃癌の予後診断マーカーおよび治療標的
US12606872B2 (en) 2022-11-16 2026-04-21 Universal Diagnostics, S.A. Methods for stratification and early detection of advanced adenoma and/or colorectal cancer using DNA methylation markers
TWI839307B (zh) * 2023-05-06 2024-04-11 華聯生物科技股份有限公司 利用電腦評估肝癌患者治療後病變進展及預後的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1942197A1 (de) * 2000-09-01 2008-07-09 Epigenomics AG Verfahren zur Bestimmung des Methylierungsgrades von bestimmten Cytosinen in genomischer DNA im Sequenzkontext 5'-CpG-3'
EP1497462A4 (en) 2002-03-07 2007-11-07 Univ Johns Hopkins Med GENOMIC SCREEN ON EPIGENETIC MUTED CANCER ASSOCIATED GENES
CA2519456A1 (en) 2003-03-17 2004-09-30 Michael G. Goggins Aberrantly methylated genes in pancreatic cancer
WO2005001140A2 (en) * 2003-06-23 2005-01-06 Epigenomics Ag Methods and nucleic acids for the analysis of colon cell proliferative disorders
JP2005110645A (ja) * 2003-09-16 2005-04-28 National Cancer Center-Japan 哺乳動物由来の検体の癌化度を評価する方法
WO2006064737A1 (ja) 2004-12-13 2006-06-22 National University Corporation Okayama University 遺伝子のメチル化検出方法及びメチル化検出による新生物の検査方法
JP2006166732A (ja) * 2004-12-13 2006-06-29 Okayama Univ 消化器中の新生物の検出方法
WO2006084078A2 (en) 2005-02-02 2006-08-10 Raven Biotechnologies, Inc. Jam-3 and antibodies that bind thereto
WO2006113770A1 (en) * 2005-04-15 2006-10-26 Epigenomics Ag A method for providing dna fragments derived from a remote sample
WO2007149269A2 (en) 2006-06-12 2007-12-27 Oncomethylome Sciences S.A. Methylation markers for early detection and prognosis of colon cancers
GB0614567D0 (en) 2006-07-21 2006-08-30 Snell & Wilcox Ltd Motion vector interpolation
GB0700374D0 (en) * 2007-01-09 2007-02-14 Oncomethylome Sciences S A NDRG family methylation markers
CA2676227A1 (en) * 2007-02-12 2008-08-21 The Johns Hopkins University Early detection and prognosis of colon cancers
WO2016094839A2 (en) * 2014-12-12 2016-06-16 Exact Sciences Corporation Compositions and methods for performing methylation detection assays

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015154775A (ja) * 2007-01-09 2015-08-27 エムディーエックスヘルス エスエー 選択された遺伝子のエピジェネティックな変化及び癌

Also Published As

Publication number Publication date
EP3434791B1 (en) 2020-05-27
US20150240318A1 (en) 2015-08-27
EP2650377A1 (en) 2013-10-16
US9982308B2 (en) 2018-05-29
JP2015154775A (ja) 2015-08-27
GB0700374D0 (en) 2007-02-14
JP2010515448A (ja) 2010-05-13
US12215389B2 (en) 2025-02-04
JP6141896B2 (ja) 2017-06-07
WO2008084219A8 (en) 2008-12-18
CN101680025A (zh) 2010-03-24
US10808286B2 (en) 2020-10-20
EP2069527B1 (en) 2018-06-06
EP3434791A1 (en) 2019-01-30
WO2008084219A1 (en) 2008-07-17
CA2674988C (en) 2024-04-23
US20100144836A1 (en) 2010-06-10
EP2069527A1 (en) 2009-06-17
US11149317B2 (en) 2021-10-19
CA2674988A1 (en) 2008-07-17
US8969046B2 (en) 2015-03-03
US20220064740A1 (en) 2022-03-03
US20250137070A1 (en) 2025-05-01
US20190032149A1 (en) 2019-01-31
US20180327859A1 (en) 2018-11-15
EP2650377B1 (en) 2016-12-21

Similar Documents

Publication Publication Date Title
US12215389B2 (en) Compositions for detecting epigenetic modifications
US11970746B2 (en) Fecal sample processing and analysis comprising detection of blood
JP5697448B2 (ja) 膀胱癌の検出のための新規なマーカー
US20140113286A1 (en) Epigenomic Markers of Cancer Metastasis
US20080221056A1 (en) Early Detection and Prognosis of Colon Cancers
JP2014520520A (ja) がん被験体の予後を決定する方法及び核酸

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110111

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110111

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121016

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130116

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130123

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130215

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130910

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131210

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140109

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140210

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140213

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140527

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140827

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140903

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140925

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150325

R150 Certificate of patent or registration of utility model

Ref document number: 5721950

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250